Biosimilars approved for treatment of inflammatory rheumatological diseases

Affiliations

• ¹ Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Brisbane, Queensland, Australia.
• ² Australian Research Council Training Centre for Biopharmaceutical Innovation, University of Queensland, Brisbane, Queensland, Australia.
• ³ School of Medical Sciences, St Vincent's Hospital, University of New South Wales and Department of Clinical Pharmacology, Sydney, New South Wales, Australia.